Hrt Financial LP Invitae Corp Transaction History

Hrt Financial LP

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$0.6 - $1.53 $79,540 - $202,827	-132,567 Reduced 74.11%	46,312 $28,000
Q2 2023 Aug 11, 2023	SELL	$1.05 - $1.63 $336,411 - $522,238	-320,392 Reduced 64.17%	178,879 $202,000
Q1 2023 May 12, 2023	SELL	$1.2 - $2.73 $14,727 - $33,505	-12,273 Reduced 2.4%	499,271 $674,000
Q4 2022 Feb 10, 2023	BUY	$1.71 - $3.61 $839,203 - $1.77 Million	490,762 Added 2361.48%	511,544 $951,000
Q3 2022 Nov 14, 2022	BUY	$1.9 - $8.63 $39,485 - $179,348	20,782 New	20,782 $51,000

Q2 2022 Aug 12, 2022	SELL	$2.13 - $9.01 $33,453 - $141,511	-15,706 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$6.28 - $15.59 $107,017 - $265,669	-17,041 Reduced 52.04%	15,706 $125,000
Q4 2021 Feb 14, 2022	BUY	$14.7 - $28.67 $481,380 - $938,856	32,747 New	32,747 $500,000
Q2 2021 Aug 16, 2021	SELL	$26.09 - $40.4 $1.35 Million - $2.09 Million	-51,753 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$33.06 - $56.93 $1.71 Million - $2.95 Million	51,753 New	51,753 $1.98 Million
Q1 2019 May 14, 2019	SELL	$10.65 - $25.75 $271,638 - $656,779	-25,506 Closed	0 $0
Q4 2018 Feb 15, 2019	BUY	$9.26 - $16.38 $236,185 - $417,788	25,506 New	25,506 $282,000

7.66M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.